An Interesting Interim Analysis for Bellerophon is Imminent.

This blog post was being written to discuss the interim analysis of Bellerophon Therepeutic's (BLPH) phase 3 INOvation-1 clinical trial for pulmonary arterial hypertension.  While I was still drafting it, the company announced that the trial was being stopped for futility. As a result this blog post was not completed.